Farxiga’s Approval Fuels Chronic Kidney Disease Comeback
Until this year, there were no effective treatments for chronic kidney disease. However, the recent…
Until this year, there were no effective treatments for chronic kidney disease. However, the recent…
Update (31/03/2020): AM-Pharma has raised an extra €47M on top of an existing €116M equity…
French researchers have found that the levels of certain immune cells in the blood of…
Many biotech founders and executives look to VC investors for advice and inspiration, but the…
Quanta Dialysis Technologies has raised €43.2M ($48M) to fund the commercial launch of a device…
Update (01/03/2019): Hansa Biopharma (previously named Hansa Medical) has filed an application for marketing authorization for imlifidase with…
Genetic variations in cell surface proteins are able to predict kidney transplant success, shows Austrian research,…
We take a hop, skip and a jump into Tallinn, Estonia this week. Optofluid Technologies…
Researchers at the University of Manchester have used embryonic stem cells to produce kidney tissue…
Balmes Transplantation has raised €700,000 in seed funding to run a proof-of-concept study to test…
Update (6/12/2017): Advicenne has raised a total of €27M on Euronext Paris, putting its market…
Update (6/11/2017): ADV7103 has maintained its efficacy in a 6-month extension of the Phase III study.…